Myriad Genetic Laboratories320 Wakara Waysalt Lake City Ut 84108 Pma Numberp140020 Supplement Numbers022 Date Received10 22 2021 Decision Date03 11 2022 Product Code Pjg Advisory Committee Pathology Clinical Trialsnct02032823 Supplement Typenormal 180 Day Track Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Myriad Genetic Laboratories320 Wakara Waysalt Lake City Ut 84108 Pma Numberp140020 Supplement Numbers022 Date Received10 22 2021 Decision Date03 11 2022 Product Code Pjg Advisory Committee Pathology Clinical Trialsnct02032823 Supplement Typenormal 180 Day Track Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P140020S022 MYRIAD GENETIC LABORATORIES320 Wakara Waysalt Lake City, UT 84108 PMA NumberP140020 Supplement NumberS022 Date Received10/22/2021 Decision Date03/11/2022 Product Code PJG  Advisory Committee Pathology Clinical TrialsNCT02032823 Supplement Typenormal 180 Day Track Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No	BRACAnalysis CDx®	2022-03-11